Multiple sclerosis (MS) is one of the most widespread ... defined relapses of increased disease activity and worsening symptoms. These are followed by remissions when the disease doesn’t progress.

Researchers have made more advancements in multiple sclerosis in the last five years than in the previous 70 years. Knowing ...

Migraine may be a symptom of prodromal multiple sclerosis (MS), as the risk for migraine gradually increased closer to the ...

Mikael Simons, MD, a neurologist and researcher at Technical University Munich and the Centre for Neurodegenerative Diseases ...

The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.

The menopausal transition may represent an inflection point for worsening of multiple sclerosis (MS) in women.

The onset of multiple sclerosis (MS) in older individuals correlates with a higher risk of developing primary progressive MS, faster progression to secondary progressive MS, and increased disability ...

Nov. 18, 2024 — Fampridine is currently used to improve walking ability in multiple sclerosis. A new study shows that it could also help individuals with reduced working memory, as seen in ...

The FDA has advised health care professionals and patients with multiple sclerosis that treatment with glatiramer acetate is ...